| Trial ID: | L2332 |
| Source ID: | NCT00590226
|
| Associated Drug: |
Detemir + Aspart Insulin Before Meals
|
| Title: |
Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes
|
| Acronym: |
DEAN
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00590226/results
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Detemir + aspart insulin before meals|DRUG: NPH insulin + regular insulin
|
| Outcome Measures: |
Primary: Mean AM BG (mg/dl), average AM daily BG with detemir insulin once daily plus insulin aspart before meals and NPH insulin twice daily plus regular insulin before meals in patients with DM2, during hospitalization | Secondary: Number of Patients With Hypoglycemic Events, number of patients with hypoglycemic events as defined as BG 40-59 mg/dl, during hospitalization
|
| Sponsor/Collaborators: |
Sponsor: Emory University | Collaborators: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
130
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-12
|
| Completion Date: |
2008-04
|
| Results First Posted: |
2014-06-11
|
| Last Update Posted: |
2014-06-11
|
| Locations: |
Grady Memorial Hospital, Atlanta, Georgia, 30303, United States|Rush University Medical Center, Chicago, Illinois, 60612, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00590226
|
